The MS and PhD programs in Regenerative Medicine and Technologies are designed to develop the workforce for Indiana’s rapidly expanding bioscience industry by coupling rigorous research experience with internships and international opportunities. Currently, Indiana is the second highest exporter of life sciences products in the country. We developed a curriculum in cooperation with industry partners to ensure students acquire the knowledge and skills necessary to create the next cell-based therapies, improve wound care and chronic disease management and invent novel medical devices.
“Right now, there is a deficit of people that are specifically trained toward regenerative medicine, and that’s been historically lacking, and it’s making it challenging for people who run these businesses,” said Erik Woods, PhD, co-founder, executive vice president and chief scientific officer of Ossium Health. “If you can prepare graduates with an industrial-focused curriculum, they will be in a better position to adapt and be a stronger contributor to a life sciences company, and it’s going to make everything more efficient; it’s going to lead to more commercial success and be self-sustaining.”
Chart your high-tech regenerative medicine career alongside experts and inventors
Our Master’s Program provides an introduction into translational research, with a curriculum emphasizing applied sciences and technology, device and therapy manufacturing, regulatory compliance and a required industrial or clinical internship. To graduate, students must complete a minimum of 30 credit hours. Students have access to intern with regional life sciences and regenerative medicine leaders such as Cook Biotech, Eli Lilly and Company, Roche Diagnostics and Ossium Health. The MS program is ideal for physicians, biomedical researchers, medical residents and Bachelor of Science graduates who are interested in regenerative medicine.
Our PhD program offers customizable classroom instruction and research training to train graduates on how to direct a regenerative medicine laboratory. Participants in the program receive specialized training in the regulation, manufacturing, and clinical application of basic sciences to produce regenerative medicines. A requirement of the degree is to secure an internship with regional life sciences and regenerative medicine leaders such as Cook Biotech, Eli Lilly and Company, Roche Diagnostics, and Ossium Health.
Degree requirements for both programs are available in the current University Graduate School Bulletin.
IU School of Medicine Graduate Division provides career and professional development support.
